{
    "topic": "coronavirus",
    "source": "National Review",
    "bias": 2,
    "url": "https://www.nationalreview.com/news/cdc-using-antibody-tests-to-gauge-number-of-asymptomatic-coronavirus-cases/",
    "title": "CDC Using Antibody Tests to Gauge Number of Asymptomatic Coronavirus Cases",
    "date": "2020-04-06",
    "authors": "Tobias Hoonhout, Zachary Evans, Daniel Tenreiro, Dan Mclaughlin, Matthew Scully, Kyle Smith, John Hirschauer, David Harsanyi, Jim Geraghty, Rich Lowry",
    "content": "Waiting to be tested for coronavirus , New York City , April 2 , 2020 ( Stefan Jeremiah/Reuters )\nThe Centers for Disease Control and Prevention has begun conducting antibody tests of three different groups to accurately measure the total number infected with coronavirus , including asymptomatic cases .\nThe surveys come after the Food and Drug Administration announced last week that it had authorized the first coronavirus serology test , which detects any antibodies produced by the immune system in response to the virus . The test is produced by Cellex Inc .\n\u201c Based on the totality of scientific evidence available to FDA , it is reasonable to believe that your [ Cellex Inc. \u2019 s ] product may be effective in diagnosing COVID-19 , \u201d the agency wrote in its authorization . \u201c The known and potential benefits of your product when used for diagnosing COVID-19 , outweigh the known and potential risks of your product . \u201d\nThe CDC \u2019 s intention is to identify people who have recovered from infection and are to keep some level of protection from reinfection \u2014 important criteria for allowing people to go back to work . It is targeting people who weren \u2019 t diagnosed with coronavirus , despite living in hot spots , as well as people from other areas around the country and certain exposed groups \u2014 including health-care workers \u2014 to test the overall level of virus spread . Some epidemiologists have raised the possibility that far more people have asymptomatic cases of COVID-19 than has been recorded .\nWhile it is unclear if those that recover from the virus will be immune , Dr. Anthony Fauci , the top U.S. infectious disease expert , expressed optimism last week that he would be \u201c willing to bet anything that people who recover are really protected against re-infection . \u201d\n\u201c If this virus acts like every other virus that we know , once you get infected , get better , clear the virus , then you \u2019 ll have immunity that will protect you against re-infection , \u201d Fauci said .",
    "content_original": "Waiting to be tested for coronavirus, New York City, April 2, 2020 (Stefan Jeremiah/Reuters)\n\nThe Centers for Disease Control and Prevention has begun conducting antibody tests of three different groups to accurately measure the total number infected with coronavirus, including asymptomatic cases.\n\nThe surveys come after the Food and Drug Administration announced last week that it had authorized the first coronavirus serology test, which detects any antibodies produced by the immune system in response to the virus. The test is produced by Cellex Inc.\n\nAdvertisement\n\n\u201cBased on the totality of scientific evidence available to FDA, it is reasonable to believe that your [Cellex Inc.\u2019s] product may be effective in diagnosing COVID-19,\u201d the agency wrote in its authorization. \u201cThe known and potential benefits of your product when used for diagnosing COVID-19, outweigh the known and potential risks of your product.\u201d\n\nThe CDC\u2019s intention is to identify people who have recovered from infection and are to keep some level of protection from reinfection \u2014 important criteria for allowing people to go back to work. It is targeting people who weren\u2019t diagnosed with coronavirus, despite living in hot spots, as well as people from other areas around the country and certain exposed groups \u2014 including health-care workers \u2014 to test the overall level of virus spread. Some epidemiologists have raised the possibility that far more people have asymptomatic cases of COVID-19 than has been recorded.\n\nWhile it is unclear if those that recover from the virus will be immune, Dr. Anthony Fauci, the top U.S. infectious disease expert, expressed optimism last week that he would be \u201cwilling to bet anything that people who recover are really protected against re-infection.\u201d\n\nAdvertisement\n\n\u201cIf this virus acts like every other virus that we know, once you get infected, get better, clear the virus, then you\u2019ll have immunity that will protect you against re-infection,\u201d Fauci said.",
    "source_url": "www.nationalreview.com",
    "bias_text": "right",
    "ID": "uCOlS97Zn54M7mvy"
}